Development and Validation of the Evaluation Platform in COPD (EPIC): A Population-Based Outcomes Model of COPD for Canada-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Development and Validation of the Evaluation Platform in COPD (EPIC): A Population-Based Outcomes Model of COPD for Canada

Published:2019-01-24 Issue:2 Volume:39 Page:152-167
ISSN:0272-989X
Container-title:Medical Decision Making
language:en
Short-container-title:Med Decis Making

Author:

Sadatsafavi Mohsen¹^ORCID,Ghanbarian Shahzad¹,Adibi Amin¹^ORCID,Johnson Kate¹,FitzGerald J. Mark²,Flanagan William³,Bryan Stirling⁴⁵,Sin Don²,

Affiliation:

1. Faculty of Medicine and Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, Canada

2. Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada

3. Statistics Canada, Ottawa, ON, Canada

4. Centre for Clinical Epidemiology and Evaluation, Vancouver Coastal Health Institute, Vancouver, BC, Canada

5. School of Population and Public Health, University of British Columbia, Vancouver, BC, Canada

Funder

canadian institutes of health research

Publisher

SAGE Publications

Subject

Health Policy

Link

http://journals.sagepub.com/doi/pdf/10.1177/0272989X18824098

Reference50 articles.

1. Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015

2. Management and prevention of exacerbations of COPD

3. Ten-Year Trends in Direct Costs of COPD

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Start Slow and Step Up or Hit Hard, Step Down? Finding the Right Initial Therapy for Chronic Obstructive Pulmonary Disease;Annals of the American Thoracic Society;2024-08

2. Benefit–Harm Analysis of Earlier Initiation of Triple Therapy for Prevention of Acute Exacerbation in Patients with Chronic Obstructive Pulmonary Disease;Annals of the American Thoracic Society;2024-08

3. A Cost-Effectiveness Analysis of Azithromycin for the Prevention of Acute Exacerbations of Chronic Obstructive Pulmonary Disease;Annals of the American Thoracic Society;2023-12

4. The Price Is Right: Cost-Effectiveness of Long-Term Azithromycin for Chronic Obstructive Pulmonary Disease;Annals of the American Thoracic Society;2023-12

5. Budget impact analysis of adopting primary care–based case detection of chronic obstructive pulmonary disease in the Canadian general population;CMAJ Open;2023-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3